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Abstract 
Objective: The aim of this study was to determine the 90-day subchronic toxicity of one triethylene glycol
dimethacrylate containing composite (MEDENTAL Light-Cure Composite™) orally administered to rats accor-
ding to OECD no. 48 guidelines and the requirements specified in the International Organization for Standardiza-
tion 10993-11. 
Study design: The composite was administered orally to Wistar rats during 90 days and they were observed to de-
termine changes in their behavior, eye and skin signs and other attitudes such as aggressiveness, posture, walking 
and response to handling. After 90 days they were sacrificed to determine blood alterations, special hematological 
tests were done and histopathological changes in 33 different organs were assessed. 
Results: Under the experimental conditions, our results showed that the composite tested in this study did not 
produce significant changes in clinical behavior of the animals. Microscopic review of the Hematoxilin and Eosin 
stained slides obtained from 33 analyzed organs showed no abnormal inflammatory or cytological changes and all 
hematological special tests were within normal limits. 
Conclusions: The results of this study show that under our experimental conditions the MEDENTAL Light-Cure 
Composite™ does not produce inflammatory or cytological changes suggestive of toxicity. 
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Introduction 
Since several years ago, different kinds of esthetic dental 
materials have been created for Dentistry. Some of them 
are the reinforced composites; these materials have been 
accepted as useful restorative dental materials. Howe-
ver, each one has advantages and disadvantages during 
their use as tooth restoration materials. Physical-chemi-
cal properties of these reinforced composites (hardness 
and compressive strength) are the same as conventional 
composites (1,2) and studies made on different kinds of 
dental composites showed that the most important diffe-
rence among those materials are: their ability to release 
fluoride, chemical adherence to dentin and compressi-
ve strength (1-3). Composites are new materials used 
in Dentistry with better physical, chemical, biological, 
radiological and esthetic properties. However, they have 
some adverse properties as dimensional stress, contrac-
tion during polymerization and cellular damage caused 
by their components (4). 
Recently, polyacid compounds have been added to the 
composites and now they have higher viscosity and 
strength resistance (2,4). Depending on the trademark, 
chemical composition of composites is variable and they 
are made of one organic component Bisphenol glyce-
rolate dimethacrylate (Bis-GMA) or triethylene glycol 
dimethacrylate (TEDGMA) plus another inorganic com-
ponent (glass, zirconium, barium, quartz and strontium) 
and a chemical bond (silano and polyacid groups). The 
above mentioned materials provide reduced contraction 
properties in the finally polymerized composite (2-4). 
Also, it is known that saliva has a deleterious effect de-
composing these compounds (6). 
Several studies have been published on TEDGMA ad-
verse effects under different experimental and clinical 
conditions and different parameters were evaluated 
(7-19); also, some reviews were published (8,20). 
It has been demonstrated that TEDGMA induces mito-
chondrial damage and oxidative stress in human gingi-
val fibroblasts and it causes apoptosis in primary human 
gingival fibroblasts (7,9). Other study reported that this 
compound showed a significant enhancement of glucose 
consumption and lactate production inducing GSH de-
pletion and stimulating glucose-6-phosphate dehydroge-
nase  (G6PDH) and gluthatione reductase (GR) activity 
(10). 
Studying TEDGMA metabolic effects, Engelmann et al 
(11) showed it increased the phosphomonoester concen-
tration and decreased the phosphodiesters, enhancing 
the phospholipid turnover. TEDGMA changed the me-
tabolic state of cells indicated by the slight decrease of 
nucleoside triphosphates and increasing the ratio of nu-
cleoside diphosphates to nucleoside triphosphates. The 
most remarkable effect of TEDGMA was a nearly com-
plete decline of intracellular glutathione levels. 
Kehe et al (12) reported that TEDGMA is toxic to pul-
monary cells and pointed on the risk for pulmonary cell 
damage and it significantly suppressed TNF-α secretion 
from THP-1 monocytes stimulated with bacterial lipo-
polysaccharide suggesting that this alteration may in-
fluence the biological response of tissues to material in 
an inflammatory intraoral environment (13). 
TEDGMA is toxic to human gingival fibroblasts since it 
alters the mitochondrial dehydrogenase (MTT) and the 
lactate dehydrogenase (LDH) activities (14). In another 
report, Volk et al. (15) reported that TEDGMA depletes 
intracellular GSH levels at low concentrations sugges-
ting that decrease of GSH is an early reaction which is 
triggered prior to other cytotoxic alterations. Geurtsen et 
al. (16) found that TEDGMA has a very high cytotoxici-
ty potential tested in human primary fibroblast cultures. 
Wataha et al. (20) concluded that TEDGMA containing 
composites affect or alter cellular functions in Balb/c 
3T3 fibroblasts. 
The genetic toxicology of TEDGMA was recently re-
viewed by Schweikl et al. (17) and Geurtsen and Le-
yhausen (8) wrote on its chemical and biological inte-
ractions.
There are few reports on skin reactions associated to 
TEDGMA: Kanerva (18) reported on the skin allergic 
reactions to TEDGMA in 8.9% of the patients tested and 
Katsuno et al. (19) demonstrated that three TEDGMA 
containing dentin bonding systems caused contact der-
matitis in the skin of guinea pigs. Although, the patho-
genic mechanism is not well known (19,21). 
For this reason, the aim of this study was to know the 90-
day oral toxicity of a TEDGMA containing dental com-
posite (MEDENTAL Light-Cure Composite™) orally 
administered to rats according to OECD no. 48 guideli-
nes and the requirements specified in the ISO 10993-11 
(22,23) hypothesizing that no toxic effects exists under 
our experimental conditions.
 
Materials and Methods 
Twenty Wistar rats, ten males and ten females, nine 
weeks old, clinically healthy were used. They were 
maintained in the Bioterio of the División de Estudios 
de Posgrado e Investigación, Facultad de Odontología. 
Universidad Nacional Autónoma de México. The proto-
col of this study was approved by the Ethics Committee 
of our institution. 
To perform the current study the recommendations of 
the OECD no. 48 guidelines and the requirements speci-
fied in the ISO 10993-11 were followed (21,22). These 
documents recommend the use of 20 rats, ten females 
and ten males. At the beginning of the study, all the ani-
mals weighted among 230g and 250g then, they were 
weighted each week and reviewed each day for beha-
viour and clinical signs in eyes, skin, mucous membra-
nes, muck and urine. 
The TEDGMA containing composite (Light Cure Com-
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organs with no inflammatory, necrotic, degenerative or 
toxicological changes. Although there were minor chan-
ges in the hematological tests, all of them were always 
within normal limits. 
 
Discussion
There are several previous studies using purified TEDG-
MA in various cell cultures (7,9-16). Results from these 
studies showed that this compound is toxic inhibiting 
cell metabolism and provoking cell damage. Also, other 
authors reported on the skin reactions applying TEDG-
MA in humans and guinea pigs (18,19). These results 
prompted us to test if the commonly used restorative 
material MEDENTAL Light-Cure Composite™ produ-
ced clinical or microscopic changes. 
During the clinical test we performed to the animals, we 
did not find changes in the evaluated parameters. Our 
microscopic review of the samples from the 36 selected 
organs, evidence of inflammatory or pathologic cellular 
change was not found. Results of our study strongly su-
ggest that ingestion of the well-polymerized composite 
we tested (MEDENTAL Light-Cure Composite™) did 
not produce clinical toxicity, behavioural or cytotoxic 
changes to the studied organs of the animals. Results 
of this study suggest that when they are used under the 
appropriate clinical conditions (as suggested by the 
manufacturers) and inadvertently ingested, these poly-
merized composites are clinically safe. It appears that 
releasing of the “non-polymerized components” of the 
tested composite during 90 days within the gastrointes-
tinal apparatus of the experimental animals and their ab-
sorption to the blood stream did not produce pathologic 
changes in the studied animals. Results from this study 
also suggest that in well-polymerized composites their 
components did not diffuse to the digestive tract and will 
not produce systemic alterations. It should be pointed 
out that studies on releasing of these compounds from 
composites simulating clinical conditions at different 
days should be done. 
The results of this study show that the MEDENTAL 
Light-Cure Composite™ does not produce toxicity 
changes under the employed experimental conditions. 
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